ABSTRACT
We extended the use of Drosophila beyond being a model for signaling pathways required for pattern recognition immune signaling and show that the fly can be used to identify genes required for pathogenesis and host-pathogen interactions. We performed a forward genetic screen to identify Drosophila mutations altering sensitivity to the intracellular pathogen Listeria monocytogenes. We recovered 18 mutants with increased susceptibility to infection, none of which were previously shown to function in a Drosophila immune response. Using secondary screens, we divided these mutants into two groups: In the first group, mutants have reduced endurance to infections but show no change in bacterial growth. This is a new fly immunity phenotype that is not commonly studied. In the second group, mutants have a typical defense defect in which bacterial growth is increased and survival is decreased. By further challenging mutant flies with L. monocytogenes mutants, we identified subgroups of fly mutants that affect specific stages of the L. monocytogenes lifecycle, exit from the vacuole or actin based movement. There is no overlap between our genes and the hundreds of genes identified in Drosophila S2 cells fighting L. monocytogenes infection using genome wide RNAi screens in vitro. By using a whole animal model and screening for host survival, we revealed genes involved in physiologies different than those that were found in previous screens, which all had defects in defensive immune signaling.
INTRODUCTION
Intracellular pathogens are responsible for a large group of infectious diseases; for example, more than 500 million people worldwide suffer from tuberculosis, AIDS and malaria each year (http://www.who.int). By residing in a host cell, these pathogens protect themselves from some host immune responses and drug therapies. The ability to enter and survive within a host cell requires a close and intricate interaction between pathogen and host; by manipulating host processes, pathogens can prevent immune responses or subvert host processes to aid in infection. Moreover, these in vitro systems are obviously limited in their ability to explore how whole-animal physiologies interacts with an infecting microbe and how L. monocytogenes can enter and survive in a wide variety of cell types.
L. monocytogenes is a Gram
To overcome these limitations, we performed a forward genetic screen in whole Drosophila to identify host genes required to survive infections. We had three goals.
First we wanted to cast a wider net than has been previously used to measure immunity in Drosophila. Much of what we know about fly immunity has been deciphered using extracellular microbes in immunocompromised flies. By using L. monocytogenes in our study we were able to identify host genes important for survival of an intracellular infection. These genes may be specific to a L. monocytogenes infection, intracellular pathogens in general or a variety of pathogens. By coupling survival and bacterial proliferation as our output phenotypes, we were able to identify mutants with defense defects as well as lines with pathological defects -those that die from the disease faster without altered bacterial load. We hypothesize that this second class of mutants is less able to endure the stress of an infection. Second, we wanted to determine whether genes required to survive infection in whole flies were the same as those identified in cultured cells by RNAi screens. By doing this, our screen would reveal differences in the host genes involved in the interactions between whole-animal physiology and the microbe, as well as those host genes involved in the interactions between one cell type and the infecting microbe. Third, we wanted to probe the host contributions to the infection because most studies involving host-pathogen interactions with an intracellular pathogen have focused on identifying microbial factors required for infection.
The Drosophila innate immune response has three arms: First, the cellular immune response depends on circulating phagocytitic cells that can engulf and clear foreign microbes. Second, the melanization response produces melanin and toxic reactive oxygen species at wounds and sites of infection. The third branch is the humoral immune response, which involves the production of antimicrobial peptides (AMP) by the fat body. These AMPs are produced largely under the control of the Toll and IMD pathways. Both of these pathways are activated by microbial elicitors and disruption of these pathways immunocompromises the fly such that the fly becomes sensitive to normally non-pathogenic bacteria like E. coli (LEMAITRE et al. 1995 We identified 18 mutants with increased sensitivity to L. monocytogenes infection. None of these genes were described previously to have immune or pathogenesis functions. Secondary screens grouped these mutants into phenotypic classes. The flies can be split into classes based on their ability to control the growth of L. monocytogenes. We define one group as having defects in endurance and suspect that it has difficulties controlling pathogenesis because mutant flies die faster than wild type flies even though the bacterial load is the same as in wild type flies. A second class appears to lack defense functions. We define this group as immunocompromised because it shows increased fly death that is correlated with rapid growth of L. monocytogenes.
The mutants can also be split into either sensitive or wild type classes based on their response to Staphylococcus aureus or Salmonella typhimurium. Secondary screens that used L. monocytogenes mutants allowed us to determine that three of our fly mutants may be acting at the vacuole and cytoplasmic stages of the bacteria lifecycle. Thus, by screening for survival as an endpoint instead of monitoring the transcriptional output of Toll or imd signaling, we identified host genes involved in immunity and pathogenesis that have not been identified previously. Thirty five-to seven-day old male flies per line were infected as before and the death rate of the mutant flies for each line was compared directly to the death rate of wild type control flies using Graphpad Prism software. Using log rank analysis, the p-value was determined. Lines that exhibited a death rate with a p-value less than p = 0.05 for all three re-tests were considered positive mutants. experiments. Using an unpaired t-test, the p-value was determined. Mutant lines that exhibited a p-value less than p = 0.05 for all three retests were considered to have significantly different bacterial growth compared to wild-type control.
MATERIALS AND METHODS

Flies
L. monocytogenes mutants. For infection of adult flies with both DP-L2161 and DP-L3078, bacteria were grown at 37 o C overnight without shaking. Thirty five-to seven-day old male flies per mutant line were infected for three independent replicates for each mutant fly line and flies were injected with approximately 1000 CFUs. The death rate for each line was directly compared to a wild-type control and analyzed using Graphpad Prism software as described above.
Verification of PiggyBac insertion site. Inverse PCR was done to determine the insertion site for the pBac element following a protocol provided by Exelixis. Briefly, Genomic DNA from each mutant fly line was isolated using the Qiagen DNeasy kit. 5' and 3' end digestions were done using Sau3AI and HinP1 respectively and incubated at 
RESULTS AND DISCUSSION
Screening for host genes important for survival: To search for host genes that are important for surviving an infection, we conducted a forward genetic screen in a mutant population of Drosophila and monitored death rates following challenge with L. The candidate mutants were tested in three independent experiments and the death curves for each were compared to the wild-type control and statistical analysis was done. After three rounds of re-testing more than 80% of these mutants were considered false positives and a total of 18 mutants, all with increased sensitivity to infection, were identified as positive mutants that affect host susceptibility to L. monocytogenes infection ( Table 2) .
monocytogenes. L. monocytogenes establishes a lethal infection upon injection into
For our study, we define any fly that exhibits a reproducible, significantly different faster death rate compared to wild type flies as sensitive and any fly with a slower death rate compared to wild type as resistant. We injected the positive mutants with media alone to confirm that the increased mortality was infection-dependent (data not shown).
Identification of genes:
A benefit of using the Exelixis pBac collection is that the insertion sites of the transposons for the mutants in the collection are publicly available.
The Bloomington Drosophila Stock center (http://flystocks.bio.indiana.edu) has verified the reported insertion sites. For additional verification, we identified the pBac element insertion site in each of our positive mutants using iPCR and by BLAST sequence analysis of the flanking DNA sequences. Our gene identities agree with those reported by Exelixis (Table 3) . We also outcrossed our 18 mutants to the parental strain and challenged the F4 generation with L. monocytogenes to reduce the possibility of background effects on host survival. Using the Computed Gene (CG) numbers for the genes we determined the Gene Ontology (GO) terms from Flybase (http://flybase.bio.indiana.edu) and listed in Table 3 . 
Phenotypic characterization of mutants -defense defects versus endurance defects:
To distinguish which of our mutants had defects in immunity versus pathogenesis, we performed three secondary screens. First, we measured L. monocytogenes growth to determine whether flies had a defect in preventing growth of this microbe. Second, we measured survival when infected with S. aureus to determine whether the mutants had a general defect in preventing Gram-positive bacterial growth (Toll mutants are very sensitive to both these microbes). Third, we measured survival when infected with S. typhimurium to determine whether the mutants were sensitive to
Gram-negative bacteria (as might be expected for IMD pathway mutants) (Table 4) . LLO and that the knocked down genes were involved in controlling LLO toxicity (CHENG et al. 2005) . This model could also apply to our mutants; however, we find that our mutants are also sensitive to S. aureus and presumably sensitivity to S. aureus is not caused by the same perturbed process that might result in sensitivity to LLO. Perhaps this mutant affects a more general process involved in sensing bacteria.
CG32706 is sensitive to ∆hly mutants but is comparatively insensitive to ∆actA infection. That is, even though the ∆hly strain is defective in vacuole escape, it kills this mutant fly line with similar kinetics as wild-type L. monocytogenes. Yet this fly line is resistant to L. monocytogenes that lack ActA and are defective in cell-to-cell spread.
Perhaps in these flies, LLO is not required for L. monocytogenes to be released into the cytosol. Similar phenotypes have been observed in in vitro screens in which genes involved in later stages of vesicular trafficking had been knocked down (CHENG et al.
2005).
gr28b is sensitive to ∆hly and ∆actA L. monocytogenes. As shown above, gr28b
is sensitive to L. monocytogenes and S. aureus, but has increased resistance to S. monocytogenes in the gr28b mutant may be an extracellular population.
Members of immunity pathways were not identified: Two known immunity
genes were present in the collection of mutant flies we tested, (IMD and kenny). Because previous studies of fly immunity have primarily focused on the Toll and Imd pathways, we anticipated that these two genes would be identified from our screen. These mutants had median times to death of two days, but were not tested further because they were outside of our cutoff of a median time to death of one day. As we screened a relatively small number of mutants, it is possible that we did not hit any members of the Toll signaling pathway because of our small sample size. In addition, some Toll pathway mutants would not meet our viability requirement and we be excluded. Regardless, this screen demonstrates that fighting an infection and the interactions that occur between host and pathogen are complex, and many processes in addition to the pathways regulating AMP transcription are involved.
The importance of performing both in vivo and in vitro screens: We compared our list of mutant genes with the hundreds of genes identified in RNAi screens monitoring L. monocytogenes growth in cultured Drosophila cells. Because many mutations in essential functions would have a lethal phenotype in the whole fly, we anticipated that we would not find some genes in the whole fly that were identified in vitro. Conversely, we also expected to find genes that were important in the whole animal but not in tissue culture. Nonetheless, we expected significant overlap between the sets of genes isolated in these two screens; instead, we found no overlap. The screen by AGAISSE et al. was a genome wide screen and theoretically all of our mutants should have been tested in that screen (AGAISSE et al. 2005 ). The dsRNA library used by CHENG et al. contained eight of our positive mutants, none of which were identified from their in vitro screen (see Table 3 ). Both of these in vitro screens selected for bacterial phenotypes, including growth and vacuole escape, and utilized one cell type.
The majority of genes identified from these in vitro screens are, not surprisingly, involved in vesicular trafficking and phagocytosis. By screening for host survival in a whole animal model, we were able to identify different host genes involved in a variety of processes during infection including the immune response and pathogenesis.
Conclusions:
In the present study we demonstrate the power of combining two genetically tractable organisms; one host and one pathogen, to reveal a previously uncharacterized group of genes involved in immunity and pathogenesis. Previous genetic studies using each organism separately greatly limit the scope of genes and processes that can be identified. The use of Drosophila to study the innate immune response to infection facilitated our understanding of signaling events that lead to the production of whole fly model, we could probe the host contributions to infection that extend to processes beyond those found by other screens and uncovered genes that were not discovered by the other methods. were considered positive hits and tested further to eliminate any false positives. The candidate mutants were tested in three independent experiments and the death curves for each were compared to the wild-type control and log rank statistical analysis was done. Lines that exhibited a death rate with a p-value less than p = 0.05 for all three re-tests were considered positive mutants. After three rounds of re-testing more than 80% of these mutants were considered false positives and a total of 18 mutants, all with increased sensitivity to infection, were identified as positive mutants that affect host susceptibility to L. monocytogenes infection. 4 CFU of S. typhimurium and the survival of the flies was monitored over the course of the infection. The growth of L. monocytogenes in mutant lines was determined as described in Materials and Methods. + indicates increased growth or sensitivity compared to wild-type flies, -indicates resistance or decreased growth compared to wild type flies. 0 indicates no change in sensitivity or growth compared to wild type. * indicates increased growth at 24 hrs post-infection only. ** indicates increased growth at 48 hrs post-infection only. Statistical analysis on survival curves was done using log rank analysis and lines with p < 0.05 were considered statistically significant. Statistical analysis on bacterial growth was done using t-test and lines with p < 0.05 were considered statistically significant. CFUs of S. typhimurium and survival was monitored. The death rate of each mutant line was compared to a wild-type control and statistical analysis was done as described in the methods section. Each mutant line was tested in three independent experiments. Supporting Figure 4 . Growth of Listeria 10403S in Drosophila mutants. Mutant lines were injected with 10 3 CFUs of wild-type Listeria. Flies were homogenized at 0, 24 and 48 hrs post-infection to quantify bacterial loads as described in the methods section. An unpaired t-test was done to identify mutants that had significantly different bacterial loads compared to wild-type flies (* p < 0.05 or ** p < 0.005). Figure 5 . Survival curves of Drosophila mutants infected with ∆hly Listeria. Mutant flies were injected with 10 3 CFUs of Listeria strain 10403S (squares) or DP-L2161 (diamonds). Survival was monitored and the death rate of each mutant for each bacteria strain tested was compared. Statistical analysis was performed as described in the methods section. Each mutant line was tested in three independent experiments.
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Supporting
Supporting Figure 6 . Survival curves of Drosophila mutants infected with ∆actA Listeria. Mutant flies were injected with 10 3 CFUs of Listeria strain 10403S (squares) or DP-L3078 (diamonds) and survival was monitored. The death rate of each mutant for each bacteria strain was compared and statistical analysis was done as described in the methods section. Each mutant line was tested in three independent experiments.
